Sanaluz

JUN 18, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Oxycodone AND Acetaminophen (REMS)

U.S. Food and Drug Administration

FDA supplemental approval action for an existing opioid–acetaminophen combination product; regulatory record documenting REMS requirement but not clinical efficacy or safety trial data.